CELL-BASED ASSAY FOR DETERMINING THE IN VITRO TUMOR KILLING ACTIVITY OF CHIMERIC ANTIGEN EXPRESSING IMMUNE CELLS | Patent Publication Number 20220057381
US 20220057381 A1Publication DateFeb 24, 2022
Original Assignee
Current AssigneeJanssen Biotech Inc.
Inventor/ApplicantsJ. KENDALL WILLIAMS
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.